The US Food and Drug Administration (FDA) has granted 510(k) clearance for Mendaera’s Focalist, a handheld robotic system designed to improve the precision of ultrasound-guided needle placement.

Forbes contributors publish independent expert analyses and insights. Sai writes about healthcare, innovation and technology. Healthcare robotics pioneer Mendaera announced today that it has received ...

A healthy 63-year-old woman with very bothersome urinary frequency and urgency, recalcitrant to medications, elected to proceed with a peripheral nerve evaluation in the office. The external anatomy ...

Pioneering a new category of robotics in healthcare, Mendaera’s Focalist™ System, cleared for precise instrument placement during ultrasound-guided procedures, is poised to transform one of medicine’s ...

Xact Medical is on a mission to make needles more precise for cardiac catheterizations and other procedures. Cincinnati Children’s Hospital and Israel’s Ben Gurion University announced its launch on ...

SAN MATEO, Calif.--(BUSINESS WIRE)--Mendaera™, Inc., a healthcare technology company developing next-generation robotics technology to simplify ultrasound-guided needle procedures, today announced the ...

A research team has developed an intravenous (IV) needle that softens upon insertion, minimizing risk of damage to blood vessels and tissues. Once used, it remains soft even at room temperature, ...

Intraosseous catheterization may be used to administer fluids or medications to small mammals, particularly when intravenous access cannot be established. This column describes the necessary equipment ...

The MarketWatch News Department was not involved in the creation of this content. WALLINGFORD, Conn., Nov. 12, 2025 (GLOBE NEWSWIRE) -- X9, Inc. today announced positive results from its ...

Optical percutaneous needle biopsy techniques are revolutionizing tumor diagnostics, enabling real-time analysis and improving the accuracy of tissue sampling.